{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:06:52Z","timestamp":1758416812094,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jns.2021.117603","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T02:34:16Z","timestamp":1628044456000},"page":"117603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effect of prior antiplatelet therapy on large vessel occlusion in patients with non-valvular atrial fibrillation newly initiated on apixaban"],"prefix":"10.1016","volume":"428","author":[{"given":"Kou","family":"Tokuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiro","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotoshi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanta","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Ezura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masunari","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihito","family":"Fukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketo","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuminori","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norito","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2021.117603_bb0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000177924","article-title":"Bleeding with antithrombotic therapy study group, antithrombotic therapy influences location, enlargement, and mortality from intracerebral hemorrhage. The bleeding with antithrombotic therapy (BAT) retrospective study","volume":"27","author":"Toyoda","year":"2009","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2021.117603_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212354","article-title":"RELAXED study group, rivaroxaban administration after acute ischemic stroke: the RELAXED study","volume":"14","author":"Yasaka","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2021.117603_bb0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/ijs.12431","article-title":"Prior antiplatelet agent use and outcomes after intravenous thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: a meta-analysis of cohort studies and randomized controlled trials","volume":"10","author":"Pan","year":"2015","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.jns.2021.117603_bb0020","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/neurintsurg-2017-013532","article-title":"Antiplatelet pretreatment and outcomes following mechanical thrombectomy for emergent large vessel occlusion strokes","volume":"10","author":"Pandhi","year":"2018","journal-title":"J. Neurointerv. Surg."},{"key":"10.1016\/j.jns.2021.117603_bb0025","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/jcm7120518","article-title":"Prior use of antiplatelet therapy and outcomes after endovascular therapy in acute ischemic stroke due to large vessel occlusion: a single-center experience","volume":"7","author":"Merlino","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jns.2021.117603_bb0030","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.10.015","article-title":"Committee of Recovery by endovascular salvage for cerebral ultra-acute embolism (RESCUE)-Japan study group, predictors of symptomatic intracranial hemorrhage after endovascular therapy in acute ischemic stroke with large vessel occlusion","volume":"26","author":"Sugiura","year":"2017","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2021.117603_bb0035","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/1747493020946975","article-title":"MR CLEAN registry investigators, prior antiplatelet therapy in patients undergoing endovascular treatment for acute ischemic stroke: results from the MR CLEAN registry","volume":"16","author":"van de Graaf","year":"2021","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.jns.2021.117603_bb0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12975-020-00839-4","article-title":"Safety of early administration of apixaban on clinical outcomes in patients with acute large vessel occlusion","volume":"12","author":"Yoshimura","year":"2021","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.jns.2021.117603_bb0045","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2021.117603_bb0050","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1161\/01.STR.25.11.2220","article-title":"Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group","volume":"25","author":"Lyden","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2021.117603_bb0055","first-page":"1534","article-title":"Use of the Alberta stroke program early CT score (ASPECTS) for assessing CT scans in patients with acute stroke","volume":"22","author":"Pexman","year":"2001","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jns.2021.117603_bb0060","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(00)02237-6","article-title":"Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score","volume":"355","author":"Barber","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2021.117603_bb0065","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00415-010-5787-x","article-title":"Diffusion-weighted ASPECTS as an independent marker for predicting functional outcome","volume":"258","author":"Tei","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.117603_bb0070","first-page":"382","article-title":"TIMI, TIBI, TICI: I came, I saw, I got confused","volume":"28","author":"Tomsick","year":"2007","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jns.2021.117603_bb0075","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/STROKEAHA.109.573477","article-title":"Japan Alteplase clinical trial II group, effects of 0.6 mg\/kg intravenous alteplase on vascular and clinical outcomes in middle cerebral artery occlusion: Japan Alteplase clinical trial II (J-ACT II)","volume":"41","author":"Mori","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2021.117603_bb0080","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/STROKEAHA.115.010049","article-title":"The Heidelberg Bleeding Classification: classification of bleeding events after ischemic stroke and reperfusion therapy","volume":"46","author":"von Kummer","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2021.117603_bb0085","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jns.2021.117603_bb0090","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jacc.2012.03.019","article-title":"Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation","volume":"60","author":"Lip","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jns.2021.117603_bb0095","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa1515510","article-title":"Chalmers, ENCHANTED Investigators and Coordinators, Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke","volume":"374","author":"Anderson","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2021.117603_bb0100","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"RE-LY steering committee and investigators, Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2021.117603_bb0105","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2021.117603_bb0110","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2021.117603_bb0115","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"ENGAGE AF-TIMI 48 investigators, edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2021.117603_bb0120","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.10.014","article-title":"Recovery by endovascular salvage for cerebral ultra-acute embolism (RESCUE)-Japan registry investigators, efficacy of endovascular treatment for acute cerebral large-vessel occlusion: analysis of nationwide prospective registry","volume":"23","author":"Yoshimura","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2021.117603_bb0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/ijs.12459","volume":"10","author":"Saver","year":"2015","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.jns.2021.117603_bb0130","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(12)61299-9","article-title":"TREVO 2 Trialists, Trevo versus merci retievers for thrombectomy revascularization of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial","volume":"380","author":"Nogueira","year":"2012","journal-title":"Lancet."},{"key":"10.1016\/j.jns.2021.117603_bb0135","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.amjmed.2004.04.017","article-title":"Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan","volume":"117","author":"Morimoto","year":"2004","journal-title":"Am. J. Med."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21002975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21002975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:57:34Z","timestamp":1758383854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21002975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":27,"alternative-id":["S0022510X21002975"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.117603","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of prior antiplatelet therapy on large vessel occlusion in patients with non-valvular atrial fibrillation newly initiated on apixaban","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.117603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117603"}}